Form 4 for HIPO Hippo Holdings Inc.
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001567619-22-004803 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-16 | 2022-02-14 | HIPO | Pinkovezky Aviad | Chief Product Off | M - OptEx | $0.16 | +86.9K | 288.5K | +43% | +$13.9K |
| D | 2022-02-16 | 2022-02-14 | HIPO | Pinkovezky Aviad | Chief Product Off | M - OptEx | $0.00 | -86.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 86,929 | $0.16 | 288,452 | D | — | — | (F1) Includes 201,523 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-14 | M | D | 86,929 | $0.00 | 0 | D | $0.16 · — to 2028-01-23 | 86,929 Common Stock | (F4) The shares underlying the option are fully vested and exercisable. |